Antonio Miguel Hernández Martínez

Ruiz J, Rios A, Rodriguez JM, Paredes M, Soriano V, Oviedo MI, Hernandez AM, Parrilla P. Incidental versus clinical diagnosis of papillary thyroid microcarcinoma. Long-term prognosis. Endocrinol Diabetes Nutr (Engl Ed). 2020 May;67(5):317-325. doi: 10.1016/j.endinu.2019.09.012. Epub 2019 Dec 24. English, Spanish. PubMed PMID: 31882257.

AÑO: 2020; IF: 1.417

31882257

Ruiz-Pardo J, Rios-Zambudio A, Rodriguez-Gonzalez JM, Paredes-Quiles M, Soriano-Gimenez V, Oviedo-Ramirez MI, Hernandez-Martinez AM, Parrilla-Paricio P. Results of treatment of papillary thyroid microcarcinoma adapted to risk of recurrence. Cir Cir. 2020;88(5):576-583. doi: 10.24875/CIRU.20001560. PubMed PMID: 33064693.

AÑO: 2020; IF: 0.361

33064693

Ruiz Pardo J, Rios A, Rodriguez JM, Paredes M, Soriano V, Oviedo MI, Hernandez AM, Parrilla P. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma. Cir Esp (Engl Ed). 2020 Apr;98(4):219-225. doi: 10.1016/j.ciresp.2019.10.003. Epub 2020 Jan 21. English, Spanish. PubMed PMID: 31980154.

AÑO: 2020; IF: 1.653

31980154

Asensio Lopez MDC, Lax A, Hernandez Vicente A, Saura Guillen E, Hernandez-Martinez A, Fernandez Del Palacio MJ, Bayes-Genis A, Pascual Figal DA. Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status. Sci Rep. 2020 Aug 11;10(1):13553. doi: 10.1038/s41598-020-70454-8. Erratum In: Sci Rep. 2020 Oct 9;10(1):17266. PubMed PMID: 32782412; PubMed Central PMCID: PMC7419540.

AÑO: 2020; IF: 4.379

32782412

Febrero B, Rodriguez JM, Rios A, Segura P, Perez-Sanchez B, Torregrosa N, Hernandez AM, Parrilla P. Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort. Eur J Surg Oncol. 2019 Apr;45(4):625-630. doi: 10.1016/j.ejso.2018.09.002. Epub 2018 Oct 17. PubMed PMID: 30366876.

AÑO: 2019; IF: 3.959

30366876